FDA
approval
· 2023-11-28
FDA Approved: OXALIPLATIN — Supplemental Application (Sandoz Inc)
Summary
FDA approved a supplemental application for oxaliplatin submitted by Sandoz Inc., approving a generic version of the chemotherapy drug. The approval is under th…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OXALIPLATIN (OXALIPLATIN)